These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 22752494)

  • 41. Friedreich ataxia: new pathways.
    Pandolfo M
    J Child Neurol; 2012 Sep; 27(9):1204-11. PubMed ID: 22752488
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Measuring Inhibition and Cognitive Flexibility in Friedreich Ataxia.
    Corben LA; Klopper F; Stagnitti M; Georgiou-Karistianis N; Bradshaw JL; Rance G; Delatycki MB
    Cerebellum; 2017 Aug; 16(4):757-763. PubMed ID: 28229372
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sensitivity of spatiotemporal gait parameters in measuring disease severity in Friedreich ataxia.
    Milne SC; Hocking DR; Georgiou-Karistianis N; Murphy A; Delatycki MB; Corben LA
    Cerebellum; 2014 Dec; 13(6):677-88. PubMed ID: 25022367
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rating disease progression of Friedreich's ataxia by the International Cooperative Ataxia Rating Scale: analysis of a 603-patient database.
    Metz G; Coppard N; Cooper JM; Delatycki MB; Dürr A; Di Prospero NA; Giunti P; Lynch DR; Schulz JB; Rummey C; Meier T
    Brain; 2013 Jan; 136(Pt 1):259-68. PubMed ID: 23365101
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnosis and treatment of Friedreich ataxia: a European perspective.
    Schulz JB; Boesch S; Bürk K; Dürr A; Giunti P; Mariotti C; Pousset F; Schöls L; Vankan P; Pandolfo M
    Nat Rev Neurol; 2009 Apr; 5(4):222-34. PubMed ID: 19347027
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Measuring disease progression in giant axonal neuropathy: implications for clinical trial design.
    Roth LA; Marra JD; LaMarca NH; Sproule DM
    J Child Neurol; 2015 May; 30(6):741-8. PubMed ID: 25186661
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A 22-Year Follow-up Study of Long-term Cardiac Outcome and Predictors of Survival in Friedreich Ataxia.
    Pousset F; Legrand L; Monin ML; Ewenczyk C; Charles P; Komajda M; Brice A; Pandolfo M; Isnard R; Tezenas du Montcel S; Durr A
    JAMA Neurol; 2015 Nov; 72(11):1334-41. PubMed ID: 26414159
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The wobbly child: an approach to inherited ataxias.
    Bernard G; Shevell M
    Semin Pediatr Neurol; 2008 Dec; 15(4):194-208. PubMed ID: 19073328
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Early onset of Friedreich's ataxia in a compound heterozygote.
    McGovern MC; Stewart M; Morrison PJ; Webb D; Hawkins S
    Arch Dis Child; 2000 Jul; 83(1):74-5. PubMed ID: 10869006
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Progression characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS): a 2 year cohort study.
    Reetz K; Dogan I; Hilgers RD; Giunti P; Mariotti C; Durr A; Boesch S; Klopstock T; de Rivera FJR; Schöls L; Klockgether T; Bürk K; Rai M; Pandolfo M; Schulz JB;
    Lancet Neurol; 2016 Dec; 15(13):1346-1354. PubMed ID: 27839651
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The molecular basis of Friedreich ataxia.
    Pandolfo M
    Adv Exp Med Biol; 2002; 516():99-118. PubMed ID: 12611437
    [No Abstract]   [Full Text] [Related]  

  • 52. Friedreich's ataxia.
    Alper G; Narayanan V
    Pediatr Neurol; 2003 May; 28(5):335-41. PubMed ID: 12878293
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Freidreich's ataxia with retained reflexes: a phenotype and genotype correlation.
    Verma R; Gupta M
    BMJ Case Rep; 2012 Dec; 2012():. PubMed ID: 23242090
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Beyond loss of frataxin: the complex molecular pathology of Friedreich ataxia.
    Evans-Galea MV; Lockhart PJ; Galea CA; Hannan AJ; Delatycki MB
    Discov Med; 2014 Jan; 17(91):25-35. PubMed ID: 24411698
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Friedreich's ataxia and frataxin: molecular genetics, evolution and pathogenesis (Review).
    Palau F
    Int J Mol Med; 2001 Jun; 7(6):581-9. PubMed ID: 11351269
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Toward gene therapy for Friedreich ataxia-associated cardiomyopathy].
    Belbellaa B; Puccio H
    Med Sci (Paris); 2014 Oct; 30(10):842-5. PubMed ID: 25311016
    [No Abstract]   [Full Text] [Related]  

  • 57. Measuring Friedreich ataxia: Interrater reliability of a neurologic rating scale.
    Subramony SH; May W; Lynch D; Gomez C; Fischbeck K; Hallett M; Taylor P; Wilson R; Ashizawa T;
    Neurology; 2005 Apr; 64(7):1261-2. PubMed ID: 15824358
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical and genetic correlate in childhood onset Friedreich ataxia.
    Alikaşifoglu M; Topaloglu H; Tunçbilek E; Ceviz N; Anar B; Demir E; Ozme S
    Neuropediatrics; 1999 Apr; 30(2):72-6. PubMed ID: 10401688
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Longitudinal change in dysarthria associated with Friedreich ataxia: a potential clinical endpoint.
    Rosen KM; Folker JE; Vogel AP; Corben LA; Murdoch BE; Delatycki MB
    J Neurol; 2012 Nov; 259(11):2471-7. PubMed ID: 22669353
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A novel deletion-insertion mutation identified in exon 3 of FXN in two siblings with a severe Friedreich ataxia phenotype.
    Evans-Galea MV; Corben LA; Hasell J; Galea CA; Fahey MC; du Sart D; Delatycki MB
    Neurogenetics; 2011 Nov; 12(4):307-13. PubMed ID: 21830088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.